The Feasibility of Engage Therapy With Video Support for Homebound Older Adults
Study Details
Study Description
Brief Summary
The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depressive symptoms. Eligible participants will be offered the combination of Engage and Prism 2.0, called Engage-Prism. The investigators hypothesize that the intervention (Engage Therapy With Video Support) will be accepted by participants, improve depressive symptom, and be feasible to complete.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Engage is a brief therapy designed to offer a structured, stepped approach and interventions to reduce barriers to increased engagement with rewarding activities to improve depression (Alexopoulos et al, 2020). The goal is to increase participation in meaningful activities. Homebound older adults have limited social interaction given their restricted mobility and medical burden. In prior research with an intervention targeting social engagement with a technology intervention (PRISM 2.0), participants reported increased social support, decreased loneliness, increased feelings of well-being, more positive attitudes about computers, and gains in computer proficiency (Czaja et al., 2017).
Participants will be referrals from case management service. Clinicians will incorporate elements of the Prism system into therapy as appropriate, and participants will be instructed to use the Prism system at their leisure or as it pertains to their chosen "reward exposure" activities. There will be a post-therapy assessment and interview about their experience with the technology at week 9. The study will conclude with follow-up assessments at week 12.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Other: Engage Prism 2.0 Engage Prism is a 9-week program that integrates Engage- a form of behavioral talk therapy treating depression, and guided use of Prism technology- a software that aims to improve social support and interaction of older adults. |
Behavioral: Engage Prism (2.0)
Brief Behavioral Treatment for Depression (Engage) combined with tablet-based social support system (Prism 2.0)
|
Outcome Measures
Primary Outcome Measures
- Acceptability: Client Satisfaction Questionnaire (CSQ) [9 weeks (end of treatment)]
The CSQ is a 3 - item questionnaire assessing client satisfaction with the treatment provided at end of treatment (9 weeks). Scores range from 3 (least satisfied) to 12 (most satisfied).
- Acceptability: Client Satisfaction Questionnaire (CSQ) [12 weeks (post treatment)]
The CSQ is a 3 - item questionnaire assessing client satisfaction with the treatment provided assessed at 3 weeks post treatment (at 12 weeks) Scores range from 3 (least satisfied) to 12 (most satisfied).
- Feasibility: Client Enrollment [Baseline]
Feasibility will be measured as the number of clients who are referred to the program, meet eligibility and accept the intervention (versus refuse).
Secondary Outcome Measures
- Hamilton Depression Rating Scale [Baseline, 9 weeks (end of treatment)]
Change in depression scores from Baseline to 9 weeks. Scores range from 0 (no depression) to 54 (very severe depression).
- Hamilton Depression Rating Scale [Baseline, 12 weeks (post treatment)]
Change in depression score from Baseline to 12 weeks post treatment. Scores range from 0 (no depression) to 54 (very severe depression).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age at least 60 years
-
English speaking
-
Currently enrolled in case management at in 2 included agencies
-
Major depression on the SCID
-
24-item Hamilton Depression Rating Scale (HAM-D) ≥ 19
Exclusion Criteria:
-
Psychotic depression by SCID-V, i.e. presence of delusions
-
High suicide risk, i.e. intent or plan to attempt suicide in the near future
-
Presence of any Axis I psychiatric disorder
-
Presence of substance abuse other than unipolar major depression
-
History of psychiatric disorders, hypomania, are excluded
-
Acute or severe medical illness, i.e. delirium, metastatic cancer, decompensated cardiac, liver, or kidney failure, major surgery, stroke, or myocardial infarction during the three months prior to entry; or drugs often causing depression, e.g. steroids, reserpine, alpha- methyl-dopa, tamoxiphen, vincristine
-
Current involvement in psychotherapy
-
Cognitive impairment (i.e. telephone administered MoCA < 11)
-
Currently dwelling in non-community dwelling (e.g. prison, nursing home)
-
Hearing that would not allow participants to complete sessions with the RA/therapist
-
Vision impairment that would not allow the participant to use the study provided tablet
-
Inability to speak English
-
Aphasia interfering with communication
-
Literacy -assessed by reading a paragraph designed for those at 6th grade reading level
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Weill Cornell Medicine | New York | New York | United States | 10065 |
Sponsors and Collaborators
- Weill Medical College of Cornell University
- National Institute of Mental Health (NIMH)
Investigators
- Principal Investigator: Natalie C Benda, PhD, Weill Medical College of Cornell University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 20-10022828
- 3P50MH113838-02S1